Tuesday, May 17, 2016

BRIEF-Coherus Biosciences provides update on '135 IPR

* Coherus Biosciences Inc - Received favorable decision from

Us Patent and Trademark Office instituting co's petition for

inter partes review of Abbvie's U.S. Patent 8,889,135

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)